FDA expands indications for Wandercraft robotic exoskeleton
November 3, 2025
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can reliably reveal these hidden structural variants and lead to new discoveries.
As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates a regenerating liver, offering new hope for future treatments.
Now, scientists at the Medical University of Vienna and Imperial College London have developed a new method for precisely detecting the nerve signals remaining after an arm amputation and utilizing them to control an artificial arm.
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research Institute of A Coruña (INIBIC), as well as other international research groups, has developed pioneering technology that enables human kidney organoids to be produced in a scalable manner.
Imagine a surgeon in the middle of a complex operation, able to get instant biochemical feedback not from a lab down the hall, but from the very tool in their hand. This vision is now one step closer to reality thanks to researchers at the University of Chemistry and Technology, Prague (UCT Prague).
Researchers from Singapore General Hospital (SGH) and National University of Singapore (NUS) found that using pulsed electromagnetic fields to stimulate muscle tissue and mimic the effects of exercise could benefit patients with type 2 diabetes with excess belly fat.
The clearance from the US regulator broadens the company’s diagnostic imaging offerings.
InterVene announced today that it received FDA 510(k) clearance for its Recana thrombectomy catheter system.
Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.